Researchers found that GLP-1 medicines caused weight loss mainly through fat reduction, with only modest decreases in ...

Charles Barkley is an NBA legend, but for college basketball fans he has a special role in their hearts. Barkley is the ...

It might be quicker than you'd think.

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound ...

Millions of patients taking GLP-1 receptor agonists such as semaglutide have achieved dramatic weight loss, but a growing ...

Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early ...

Analysts remain intrigued by aleniglipron’s potential in the oral GLP-1RA market, though they note it is too early to compare the drug’s efficacy to Eli Lilly’s orforglipron.

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong ...

Peer-Reviewed Data Show Durable HbA1c Reduction, Significant Weight Loss, and a Favorable Safety Profile Through 48 Weeks Following a Single Endoscopic Procedure for Type 2 Diabetes ...

Testing revealed weight loss effects some Wall Street analysts believe compare favorably to Lilly’s orforglipron, which ...